belantamab mafodotin,daratumumab
gsk,janssen
['dara ', 'thio', 'belantamab,mafodotin', 'belantamab']
#eha2023 | efstathios kastritis shows data from the phase 2 emn27 trial of belantamab mafodotin monotherapy in pts with rral amyloidosis. overall orr 60%, 56% in pts with prior dara exposure. median time to response 0.5mo. #amyloidosis 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma